16 Jun 2011
(MENAFN) Business Monitor International (BMI) said that by the year 2015, Qatar’s pharmaceutical market would be expected to witness compound annual growth rate of 12.6 percent reaching USD709 million, reported Arabian Business.
BMI added that last year, the pharmaceutical sector was valued at USD392 million, and in the year 2019, it would be forecasted to become a billion dollar market, reaching USD1.10 billion in 2020.
It also said that the legislation proposed by the Supreme Council of Health and approved by Qatar Advisory Council would decrease prices and increase the availability of certain drugs via the abolition of government controls over the pricing of medicines and an ending of the monopoly that a small number of importing agents have held in the country.
It is worth noting that currently, the GCC imports 90 percent of its pharmaceutical needs.
12 May 2025
Alsharifi: “Proud of our strategic partnership with the Royal Humanitarian Foundation”
04 May 2025
BBK offers exclusive Mortgage Loans for luxury villas and apartments on Reef Island
30 Apr 2025
BBK discloses its financial results for the first quarter ended 31st March 2025
25 Mar 2025
BBK’s General Assembly Approves 35% Cash Dividend Distribution to Shareholders
12 Mar 2025
Mr. Yaser Alsharifi completes Harvard Business School Presidents’ Program in Leadership
19 Feb 2025
Bank of Bahrain and Kuwait BSC announces the transfer of HSBC Middle East, Bahrain Retail Business to BBK.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more